TrialAmerican journal of respiratory and critical care medicine2006

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.

Karina A Keogh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.